Canada - English - Health Canada

dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylene glycol) - tablet - 70mg - dasatinib (dasatinib (s)-propylene glycol) 70mg - antineoplastic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylene glycol) - tablet - 80mg - dasatinib (dasatinib (s)-propylene glycol) 80mg - antineoplastic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylene glycol) - tablet - 100mg - dasatinib (dasatinib (s)-propylene glycol) 100mg - antineoplastic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylene glycol) - tablet - 140mg - dasatinib (dasatinib (s)-propylene glycol) 140mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - healing of erosive esophagitis esomeprazole magnesium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium may be considered. maintenance of healing of erosive esophagitis esomeprazole magnesium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole magnesium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults and children 1 year or older. esomeprazole magnesium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for developing gastric ulcers. patients are considered to be at risk due to their age ( > 60)